Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | Chief Legal Officer | February 28, 2023 | March 02, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date February 28, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 84,407 |
Reported balance
After 2023-02-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-02-28 · Tax withholding · Disposed 3,792 · Balance 84,407 F1: Includes 51,285 unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 51,285 unvested restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SeaSpine Holdings Corp
Report date January 05, 2023 · Filed January 09, 2023
Section 16 reporting ended · disclosed 2023-01-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 1
1 source rowRow 1 · 2023-01-05 · Disposition to issuer · Disposed 69,628 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 28,986 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-05 · Disposition to issuer · Disposed 8,166 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 3,399 Orthofix restricted stock units. F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-01-05 · Disposition to issuer · Disposed 52,091 · Balance 0 F5: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F7: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,685 Orthofix restricted stock units. F6: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.08 · Expires 2023-11-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-05 · Disposition to issuer · Disposed 60,000 · Balance 0 F9: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $36.23 per share. F8: The option vests as to 25% of the underlying shares on November 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.19 · Expires 2024-01-27 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-01-05 · Disposition to issuer · Disposed 64,599 · Balance 0 F11: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share. F10: The option vests as to 18.75% of the underlying shares on November 1, 2016, 6.25% on December 31, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.24 · Expires 2027-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-01-05 · Disposition to issuer · Disposed 33,749 · Balance 0 F13: This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,049 shares of Orthofix at a price of $43.82 per share. F12: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.01 · Expires 2028-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-01-05 · Disposition to issuer · Disposed 52,797 · Balance 0 F15: This option was assumed by Orthofix in the merger and replaced with an option to purchase 21,979 shares of Orthofix at a price of $28.85 per share. F14: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.93 · Expires 2028-04-23 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-01-05 · Disposition to issuer · Disposed 6,045 · Balance 0 F17: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,516 shares of Orthofix at a price of $23.86 per share. F16: The option fully vested and became exercisable on June 21, 2020. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.86 · Expires 2029-01-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-01-05 · Disposition to issuer · Disposed 40,786 · Balance 0 F19: This option was assumed by Orthofix in the merger and replaced with an option to purchase 16,979 shares of Orthofix at a price of $40.50 per share. F18: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2030-02-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-01-05 · Disposition to issuer · Disposed 21,704 · Balance 0 F21: This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share. F20: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 28,986 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 3,399 Orthofix restricted stock units.
F5: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F6: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
F7: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,685 Orthofix restricted stock units.
F8: The option vests as to 25% of the underlying shares on November 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F9: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,978 shares of Orthofix at a price of $36.23 per share.
F10: The option vests as to 18.75% of the underlying shares on November 1, 2016, 6.25% on December 31, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F11: This option was assumed by Orthofix in the merger and replaced with an option to purchase 26,892 shares of Orthofix at a price of $34.09 per share.
F12: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F13: This option was assumed by Orthofix in the merger and replaced with an option to purchase 14,049 shares of Orthofix at a price of $43.82 per share.
F14: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F15: This option was assumed by Orthofix in the merger and replaced with an option to purchase 21,979 shares of Orthofix at a price of $28.85 per share.
F16: The option fully vested and became exercisable on June 21, 2020.
F17: This option was assumed by Orthofix in the merger and replaced with an option to purchase 2,516 shares of Orthofix at a price of $23.86 per share.
F18: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F19: This option was assumed by Orthofix in the merger and replaced with an option to purchase 16,979 shares of Orthofix at a price of $40.50 per share.
F20: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F21: This option was assumed by Orthofix in the merger and replaced with an option to purchase 9,035 shares of Orthofix at a price of $36.04 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2019 Filed Jan 3, 2019 16:56 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 9,914 | $18.24 | $180,831.36 |
DisclosureSEC source: 0001637761-19-000009 · wf-form4_154655254851419.xml · nonDerivative · entry 4 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,671 F4 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2019. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 16:56 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 11,885 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-19-000009 · wf-form4_154655254851419.xml · nonDerivative · entry 3 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 16:56 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 15,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-19-000009 · wf-form4_154655254851419.xml · nonDerivative · entry 2 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 16:56 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 1,122 | $6.43 | $7,209.97 |
DisclosureSEC source: 0001637761-19-000009 · wf-form4_154655254851419.xml · nonDerivative · entry 1 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,127 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (ESPP) in transactions that were exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2017, which was the first trading day of the applicable offering period. Read SEC document |
| June 29, 2018 Filed Jun 29, 2018 18:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 2,185 | $6.43 | $14,040.81 |
DisclosureSEC source: 0001637761-18-000111 · wf-form4_153031062912845.xml · nonDerivative · entry 1 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,005 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2017, which was the first trading day of the applicable offering period. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 14:30 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 35,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000052 · wf-form4_152045103652531.xml · derivative · entry 1 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,656 Underlying: Common Stock · 35,656 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2019, 2020 and 2021. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2019, 2020 and 2021. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 20:10 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 15,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000013 · wf-form4_151502820095474.xml · derivative · entry 4 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,147 Underlying: Common Stock · 15,573 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 46,720 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. F5 · derivative.expiration_date: The reporting person was granted 46,720 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 20:10 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 6,613 | $10.12 | $66,923.56 |
DisclosureSEC source: 0001637761-18-000013 · wf-form4_151502820095474.xml · nonDerivative · entry 3 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,820 F4 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on January 1, 2018. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 20:10 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 15,573 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-18-000013 · wf-form4_151502820095474.xml · nonDerivative · entry 2 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:10 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 1,184 | $6.43 | $7,608.38 |
DisclosureSEC source: 0001637761-18-000013 · wf-form4_151502820095474.xml · nonDerivative · entry 1 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,860 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2017, which was the first trading day of the applicable offering period. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 15:37 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 2,122 | $6.43 | $13,635.97 |
DisclosureSEC source: 0001637761-17-000142 · wf-form4_149928342805618.xml · nonDerivative · entry 1 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,676 F1 · kind: These shares were acquired under the Company's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · price: In accordance with the Company's 2015 Employee Stock Purchase Plan, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2017, which was the first trading day of the applicable offering period. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 12:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | SaleCommon Stock | 6,315 | $6.66 | $42,057.90 |
DisclosureSEC source: 0001637761-17-000059 · wf-form4_148950801980780.xml · nonDerivative · entry 2 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,554 F2 · shares: These shares were sold to cover tax withholding obligations related to the receipt of shares in connection with the vesting of the restricted stock units. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.66 to $6.80, inclusive. The reporting person undertakes to provide to SeaSpine, any security holder of SeaSpine, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 12:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 15,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000059 · wf-form4_148950801980780.xml · derivative · entry 3 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F4 · derivative.exercise_date: The reporting person was granted 15,309 restricted stock units on February 2, 2017, which vested in full on March 10, 2017. F4 · derivative.expiration_date: The reporting person was granted 15,309 restricted stock units on February 2, 2017, which vested in full on March 10, 2017. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 12:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 15,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-17-000059 · wf-form4_148950801980780.xml · nonDerivative · entry 1 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 16:29 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 46,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000024 · wf-form4_148641657521400.xml · derivative · entry 2 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,720 Underlying: Common Stock · 46,720 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2018, 2019 and 2020. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 16:29 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 15,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000024 · wf-form4_148641657521400.xml · derivative · entry 1 Keran Patrick L · CIK 0001372290 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,309 Underlying: Common Stock · 15,309 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on March 10, 2017. F2 · derivative.expiration_date: The restricted stock units vest in full on March 10, 2017. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 11:10 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 190 | $6.72 | $1,275.85 |
DisclosureSEC source: 0001637761-17-000002 · wf-form4_148354623743145.xml · nonDerivative · entry 1 Keran Patrick L · CIK 0001372290 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,560 F1 · kind: These shares were acquired under the Company's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.